Ledger.Open graph →
SEC Form D · filed June 7, 2018

Kitov Pharma Ltd

Offering
$8.2M
Sold
$8.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
TEL AVIV, L3
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Ran Tzror · Tel Aviv, L3DirectorGil Ben-Menachem · Tel Aviv, L3Exec · DirectorIsaac Israel · Tel Aviv, L3Exec · DirectorIdo Agmon · Tel Aviv, L3DirectorArye Weber · Tel Aviv, L3DirectorJohn Paul Waymack · Tel Aviv, L3Exec · DirectorSimcha Rock · Tel Aviv, L3Exec · DirectorHadas Reuveni · Tel Aviv, L3ExecRevital Stern-Raff · Tel Aviv, L3DirectorSteven Steinberg · Tel Aviv, L3DirectorAiden S. Redmond · New York, NYExec · DirectorCarl S. Pappo · New York, NYExec · DirectorTravis York · BOSTON, MADirectorJay Bush · BOSTON, MADirectorPaul Young · Exeter, NHDirectorStavros Koutsantonis · Exeter, NHExecMark Mcgarry · BOSTON, MADirectorKyle York · BOSTON, MAExec · DirectorStephen F. Waltrich · conshohocken, PAExec · DirectorRichard F. Lunsford · conshohocken, PADirectorJames S. Robertson · Houston, TXExec · DirectorJeffrey Grimberg · Seattle, WADirectorSteven J. Grover · Missoula, MTExec · DirectorWendy W. Dicicco · Pittsburgh, PAExec · DirectorQuinn Rotchford · Seattle, WADirectorJohn K. Mastrototaro · Dania Beach, FLDirectorSteven K. Seger · Dania Beach, FLExec · DirectorGary Pinkerton · Wall Township, NJDirectorScott Baker · Overland, KSDirectorScott Duba · Overland, KSExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗